Goldman Sachs Group Inc Cerus Corp Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Cerus Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 899,059 shares of CERS stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
899,059
Previous 703,983 27.71%
Holding current value
$1.61 Million
Previous $1.52 Million 11.78%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$1.66 - $2.42 $323,826 - $472,083
195,076 Added 27.71%
899,059 $1.7 Million
Q4 2023

Feb 13, 2024
BUY
$1.25 - $2.35 $125,636 - $236,196
100,509 Added 16.66%
703,983 $1.52 Million
Q3 2023

May 14, 2024
SELL
$1.5 - $3.07 $150,763 - $308,562
-100,509 Reduced 14.28%
603,474 $977,000
Q3 2023

Nov 14, 2023
BUY
$1.5 - $3.07 $328,198 - $671,712
218,799 Added 56.88%
603,474 $977,000
Q2 2023

May 14, 2024
SELL
$1.79 - $2.9 $420,250 - $680,853
-234,777 Reduced 37.9%
384,675 $946,000
Q2 2023

Aug 14, 2023
SELL
$1.79 - $2.9 $420,250 - $680,853
-234,777 Reduced 37.9%
384,675 $946,000
Q1 2023

May 14, 2024
SELL
$2.65 - $3.81 $974,132 - $1.4 Million
-367,597 Reduced 37.24%
619,452 $1.84 Million
Q1 2023

May 11, 2023
SELL
$2.65 - $3.81 $974,132 - $1.4 Million
-367,597 Reduced 37.24%
619,452 $1.84 Million
Q4 2022

May 14, 2024
SELL
$3.38 - $4.22 $920,590 - $1.15 Million
-272,364 Reduced 21.63%
987,049 $3.6 Million
Q4 2022

Feb 13, 2023
SELL
$3.38 - $4.22 $920,590 - $1.15 Million
-272,364 Reduced 21.63%
987,049 $3.6 Million
Q3 2022

May 14, 2024
BUY
$3.43 - $5.83 $1.36 Million - $2.31 Million
395,568 Added 45.79%
1,259,413 $4.53 Million
Q3 2022

Nov 10, 2022
BUY
$3.43 - $5.83 $1.36 Million - $2.31 Million
395,568 Added 45.79%
1,259,413 $4.53 Million
Q2 2022

May 14, 2024
BUY
$4.41 - $5.69 $704,991 - $909,614
159,862 Added 22.71%
863,845 $4.57 Million
Q2 2022

Aug 15, 2022
BUY
$4.41 - $5.69 $1.93 Million - $2.49 Million
437,101 Added 102.43%
863,845 $4.57 Million
Q1 2022

May 16, 2022
BUY
$4.81 - $6.99 $33,011 - $47,972
6,863 Added 1.63%
426,744 $2.34 Million
Q4 2021

Feb 14, 2022
BUY
$5.97 - $7.93 $210,549 - $279,675
35,268 Added 9.17%
419,881 $2.86 Million
Q3 2021

Nov 10, 2021
BUY
$4.79 - $6.68 $1.84 Million - $2.57 Million
384,613 New
384,613 $2.34 Million

Others Institutions Holding CERS

# of Institutions
153
Shares Held
144M
Call Options Held
39.6K
Put Options Held
60.9K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email